T Lymphocytes and Autoimmunity

被引:96
作者
Khan, Uqba [1 ]
Ghazanfar, Hareem [1 ]
机构
[1] St John Hosp & Med Ctr, Detroit, MI 48236 USA
来源
BIOLOGY OF T CELLS, PT A | 2018年 / 341卷
关键词
PROTEIN-TYROSINE-PHOSPHATASE; LUPUS-ERYTHEMATOSUS PATIENTS; REDUCES DISEASE-ACTIVITY; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; CELIAC-DISEASE; DOUBLE-BLIND; MOLECULAR-MECHANISMS; CLINICAL-APPLICATION; NEGATIVE SELECTION;
D O I
10.1016/bs.ircmb.2018.05.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T lymphocytes play a central role in regulation of the immune system. Both effector and regulatory T cells work in equilibrium to provide optimal immune response against foreign pathogens. Normally, T cells do not react against self-antigens because of the presence of central and peripheral immunogenic tolerance. Central tolerance eliminates autoreactive naive T cells that develop in thymus by presenting them with self-antigens on the thymic cells. The autoreactive T cells that escape thymus are subjected to additional mechanisms such as clonal anergy, ignorance, and deletion. Moreover, the regulatory T cells (Tregs), specifically CD4(+)CD25(+)Foxp3(+) Tregs, exert a tight control over autoreactive B and T cell responses in the periphery. Failure of any one of these checkpoints can cause uncontrolled expansion of these self-reactive T cells leading to the development of autoimmune diseases. In this chapter we discuss the key role of T cells in the underlying pathogenesis of autoimmune responses. We review the role of T-cell receptor and signaling pathways including costimulatory pathways. We also review T cell inhibitory receptors such as programmed cell death protein 1 and cytotoxic T lymphocyte-associated antigen 4 and T cell-related important cytokines (interleukin [IL]-2, IL-6, IL-17, IL-7, and IL-33) involved in autoimmunity. Defects in genes responsible for T-cell regulation and function are also discussed in detail which forms the basis of many important autoimmune disorders. Various therapeutic measures that target T cells in the management of autoimmune diseases are also highlighted.
引用
收藏
页码:125 / 168
页数:44
相关论文
共 155 条
[51]   LEVELS OF PERIPHERAL T-CELL TOLERANCE INDUCED BY DIFFERENT DOSES OF TOLEROGEN [J].
FERBER, I ;
SCHONRICH, G ;
SCHENKEL, J ;
MELLOR, AL ;
HAMMERLING, GJ ;
ARNOLD, B .
SCIENCE, 1994, 263 (5147) :674-676
[52]   Rapamycin reduces disease activity and normalizes T-Cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. [J].
Fernandez, David ;
Bonilla, Eduardo ;
Mirza, Naureen ;
Niland, Brian ;
Perl, Andras .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :S261-S261
[53]  
FURSZYFER J, 1970, MAYO CLIN PROC, V45, P636
[54]  
Garg Rajat, 2017, Case Rep Gastroenterol, V11, P672, DOI 10.1159/000484131
[55]   Subcutaneous Abatacept Versus Intravenous Abatacept A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate [J].
Genovese, M. C. ;
Covarrubias, A. ;
Leon, G. ;
Mysler, E. ;
Keiserman, M. ;
Valente, R. ;
Nash, P. ;
Simon-Campos, J. A. ;
Porawska, W. ;
Box, J. ;
Legerton, C., III ;
Nasonov, E. ;
Durez, P. ;
Aranda, R. ;
Pappu, R. ;
Delaet, I. ;
Teng, J. ;
Alten, R. .
ARTHRITIS AND RHEUMATISM, 2011, 63 (10) :2854-2864
[56]   Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells [J].
Gianfrani, Carmen ;
Levings, Megan K. ;
Sartirana, Claudia ;
Mazzarella, Giuseppe ;
Barba, Gianvincenzo ;
Zanzi, Delia ;
Camarca, Alessandra ;
Iaquinto, Gaetano ;
Giardullo, Nicola ;
Auricchio, Salvatore ;
Troncone, Riccardo ;
Roncarolo, Maria-Grazia .
JOURNAL OF IMMUNOLOGY, 2006, 177 (06) :4178-4186
[57]   LAG-3 in Cancer Immunotherapy [J].
Goldberg, Monica V. ;
Drake, Charles G. .
CANCER IMMUNOLOGY AND IMMUNOTHERAPY, 2011, 344 :269-278
[58]   Multistep pathogenesis of autoimmune disease [J].
Goodnow, Christopher C. .
CELL, 2007, 130 (01) :25-35
[59]   T-cell co-stimulatory pathways in autoimmunity [J].
Goronzy, Joerg J. ;
Weyand, Cornelia M. .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (Suppl 1)
[60]   Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New-Onset Type 1 Diabetes [J].
Gottlieb, Peter A. ;
Quinlan, Scott ;
Krause-Steinrauf, Heidi ;
Greenbaum, Carla J. ;
Wilson, Darrell M. ;
Rodriguez, Henry ;
Schatz, Desmond A. ;
Moran, Antoinette M. ;
Lachin, John M. ;
Skyler, Jay S. .
DIABETES CARE, 2010, 33 (04) :826-832